famotidine has been researched along with Embolism, Pulmonary in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Famotidine was administered." | 1.28 | Treatment of urokinase-related anaphylactoid reaction with intravenous famotidine. ( Heiselman, DE; Hudock, D; Vidovich, RR, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vidovich, RR | 1 |
| Heiselman, DE | 1 |
| Hudock, D | 1 |
1 other study available for famotidine and Embolism, Pulmonary
| Article | Year |
|---|---|
Treatment of urokinase-related anaphylactoid reaction with intravenous famotidine.
Topics: Aged; Anaphylaxis; Famotidine; Humans; Injections, Intravenous; Male; Pulmonary Embolism; Urokinase- | 1992 |